http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02160720-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f69bbbcc61da281886c3b5c3f2f99648 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 |
| filingDate | 1989-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cac59a21dafa80d681de3ca2273d188a |
| publicationDate | 1990-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H02160720-A |
| titleOfInvention | Pharmaceutical composition |
| abstract | PURPOSE: To obtain a pharmaceutical composition that contains a specific (thio) xanthine derivative and useful for therapy and prevention of cerebrovascular lesions and/or lesions accompanying aging of the brain. n CONSTITUTION: This pharmaceutical composition contains a compound of formula I [i) R 1 is X-CO-CH 3 (X is a hydrocarbon group replaceable with CH 3 ; R 2 and R 3 are each a 2-6C alkyl, cyclohexyl, alkoxyalkyl, etc.; Y and Z are each O; ii) R 2 is formula II (R 4 and R 5 are each a 1-4C alkyl, 1,3-dioxa-cyclohexa-2,2- diyl in combination of both groups, etc.); R 2 and R 3 are each a 1-4C alkyl, Y and Z are each O; iii) R 1 is CH 2 COCH 3 ; R 2 and R 3 are each a 2-6C alkyl; Z is S; Y is O or S; iv) R 1 is (CH 2 ) n COCH 2 ((n) is 1 or 2); either of R 2 and R 3 is a 1-6C alkyl and the other is a 2-6C alkyl; Z is O; Y is S; etc.], for example, 1,3-di-n-butyl-7-(3-oxobutyl)xanthine. Dosage of this compound is in the range of 0.002-3.5mg/kg/day, preferably 1-3mg/kg/day. n COPYRIGHT: (C)1990,JPO |
| priorityDate | 1984-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 29.